Skip to main content
Premium Trial:

Request an Annual Quote

FDA Clears Additional Flu Strains for Focus' MDx Assay

NEW YORK (GenomeWeb) – Quest Diagnostics business Focus Diagnostics today said that the US Food and Drug Administration has cleared eight additional influenza strains on the Simplexa Flu A/B & RSV Direct kit. 

The kit originally received 510(k) clearance in 2012. The additional flu strains cleared by the FDA are H7N9; H3N2 (both the Minnesota and Indiana strains; H1N1 (2011); H3N2 (the Ohio and Texas strains); and influenza B (Brisbane and Wisconsin strains). 

Focus said that the novel avian influenza A strain H7N9, which can kill as many as one-third of people it infects, and H3N2, which infects people more easily than other swine influenza virus according to the Centers for Disease Control and Prevention, are of particular concern.

"Influenza viruses constantly evolve, and virus subtypes can quickly develop and infect large populations," Hollis Batterman, medical director for infectious diseases at Focus, said in a statement. "It is vital that the tests can detect the recently circulating and geographically diverse strains."

The Simplexa Flu A/B & RSV Direct kit on the 3M Integrated Cycler is a real-time RT-PCR molecular test and was cleared for the in vitro qualitative detection and differentiation of influenza A virus, influenza B virus, and respiratory syncytial virus RNA in nasopharyngeal swabs from patients who show signs and symptoms of respiratory tract infection in conjunction with clinical and epidemiological risk factors.

 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.